Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure

Cancer Detection and Prevention

Volumn 30, Issue 6, 2006, Pages 491-498

  Habib, Samy L ^a   Said, Boctor ^a   Awad, Ahmed T ^b   Mostafa, Mostafa H ^c   Shank, Ronald C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Aflatoxin B1; Cytochrome P 450; N7 guanine AFB1adducts; Novel adenine adducts; P53 mutation; PCR; S. hematobium; S. mansoni; Schistosomiasis; Synergism

Indexed keywords

ADENINE; AFLATOXIN B1; DNA; GUANINE; PROTEIN P53;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; STATISTICAL ANALYSIS; STRAIN IDENTIFICATION;

ADULT; AFLATOXIN B1; ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA ADDUCTS; FEMALE; GENES, P53; HUMANS; LIVER NEOPLASMS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MUTATION; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 37849188603     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.10.006     Document Type: Article

References (58)

1. Yu M.W., Lien J.P., Liaw Y.F., and Chen C.J. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Cancer Epidemiol Biomarkers Prev 5 (1996) 613-619
2. Evans A.A., Chen G., Ross E.A., Shen F.M., Lin W.Y., and London W.T. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 4 (2002) 369-376
3. Montesano R., Hainaut P., and Wild C.P. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 89 (1997) 1844-1851
4. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 80 (1999) 827-841
5. Bosch F.X., Ribes J., and Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 19 (1997) 271-285
6. Okuda K. Hepatocellular carcinoma. J Hepatol 32 (2000) 225-237
7. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. Geneva: The Agency: Secretariat of the World Health Organization [distributor] 1994;45-119. (IARC monographs on the evaluation of carcinogenic risks to humans, v. 61).
8. Halim A.B., Garry R.F., Dash S., and Gerber M.A. Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 6 (1999) 915-920
9. Angelico A. Chronic liver disease in Alexandria governorate in Egypt contribution of schistosomiasis and hepatitis viruses. J Hepatol 2 (1997) 236-243
10. 1 in common Egyptian foods. J AOAC Int 79 (1996) 1124-1129
11. Abdel-Rahim A.Y. Parasitic infections and hepatic neoplasia. Dig Dis 4 (2001) 288-291
12. Badawi A.F., Mostafa M.H., Probert A., and O'Connor P.J. Role of schistosomiasis in human bladder-cancer evidence of association, etiologic factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 4 (1995) 45-49
13. Nakashima T., Okuda K., Kojiro M., Sakamato K., Kubo Y., and Shimokawa Y. Primary liver cancer coincident with schistosoma japonica. Cancer 36 (1975) 1483-1489
14. Inaba Y., Maruchi N., Matsuda M., Youshinara N., and Yamamato S. A case-control study on liver cancer with special emphasis on the possible aetiological role of schistosomiasis. Int J Epidemiol 4 (1984) 408-412
15. Nouh M., Bashi S., Laamjama M., Mofleh I., and Al-Aska M. Hepatities B virus vs. schistosomiasis and hepatocellular carcimoma in Saudi Arabia. East Afr Med J 67 (1990) 139-144
16. Domingo E.O., Warren K.S., and Stenger R.J. Increased incidence of hepatoma in mice with chronic schistosoma mansoni treated with a carcinogen. Am J Pathol 51 (1967) 307-321
17. Hashem M., and Boutros K. The influence of bilharzial infection on the carcinogenesis of the bladder. An experimental study. J Egypt Med Assoc 44 (1961) 598-606
18. Al-Aaser A.A., El-Merzabani M.M., Higgy N.A., and Abdel-Kader M.M. A study on the etiological factors of bilharzial bladder cancer in Egypt. Eur J Cancer 15 (1978) 573-583
19. Hicks R.M., James C., and Webbe G. Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl) nitrosamine on the development of urotheial neoplasia in baboon. Br J Cancer 42 (1980) 730-755
20. Wogan G.N. Aflatoxin as risk factors for hepato-cellualar carcinoma in humans. Cancer Res 52 (1992) 2114-2118
21. Van-Rosenburg S.L., Cook-Mozaffari P., Schalkwyk D.J., Van-derwatt J.J., Vincent T.J., and Purchase I.F. Hepatocellular carcinoma and dietay aflatoxin in Mozambiqu and Trankei. Br J Cancer 51 (1985) 317-726
22. Peers F., Bosch X., Koldor J., Linsell A., and Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 39 (1987) 545-549
23. 1 carcinogenecity. Soc Exp Biol Med 208 (1995) 213-247
24. Groopman J.D., Donahue R.P., Zhu J., Chen J., and Wogan G.N. Aflatoxin metabolism in humans: detection metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci USA 82 (1985) 6492-6496
25. Nayak S., Sashidhar R.B., and Bhat R.V. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins. Analyst 126 (2001) 179-183
26. 1, on the transcriptional activity of DNA template. Chromatin and soluble DNA dependent RNA polymmerases in buffalo livers. Toxicol Lett 41 (1988) 69-75
27. Sotomayor R.E., Washington M., Nguyen L., Nyang'anyi R., Hinton D.M., and Chou M. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns. Toxicol Sci 2 (2003) 329-338
28. 1 metabolism and microsomal enzyme capacities in mice liver treated with melatonin. J Med Res 19 (1998) 61-69
29. 1. Toxicology 172 (2002) 143-148
30. Sheweita S.A., and Mostafa M.M. Recovery of the hepatic carcinogen-metabolising capacity in schistosome-infected mice after treatment with the antischistosomal praziquantel. Oncol Rep 2 (1995) 155-159
31. Habib S.L., Sheweita S.A., Awad A.T., Mashaal N.M., Soliman A.A., and Mostafa H.M. Influence of Schistosoma mansoni infection on carcinogen-metabolizing capacities and in vitro aflatoxin B1 metabolism in human liver. Oncol Rep 3 (1996) 769-773
32. Chen X., Cheung S.T., So S., Fan S.T., Barry C., Higgins J., et al. Gene expression patterns in human liver cancers. Mol Biol Cell 6 (2002) 1929-1939
33. Kirk G.D., Camus-Randon A.M., Mendy M., Goedert J.J., Merle P., Trepo C., et al. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst 92 (2000) 148-153
34. Jin Y., Abe K., Sato Y., Aita K., Irie H., and Shiga J. Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China. Hepatol Res 4 (2002) 379-384
35. Shimizu Y., Zhu J.J., Han F., Ishikawa T., and Oda H. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China. Int J Cancer 2 (1999) 187-190
36. Offer H., Zurer I., Banfalvi G., Reha'k M., Falcovitz A., Milyavsky M., et al. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res 1 (2001) 88-96
37. Warren W., Biggs P.J., el-Baz M., Ghoneim M.A., Stratton M.R., and Venitt S. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 5 (1995) 1181-1189
38. Liu H., Wang Y., Zhou Q., Gui S.Y., and Li X. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. World J Gastroenterol 3 (2002) 480-482
39. Strauss MW. Preparation of genomic DNA from mammalian tissue. Current Protocols 1990;(Suppl 9, Unit 2.2).
40. Iyer R.S., Coles B.F., Raney K.D., Thier R., Guengerich F.P., and Harris T.M. DNA adduction by the potent carcinogen aflatoxin B1: mechanistic studies. J Am Chem Soc 116 (1994) 1603-1609
41. Essigmann J.M., Croy R.G., Nadzan A.M., Busby Jr., Reinhold V.N., Buchi G., et al. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci USA 74 (1997) 1870-1874
42. Baertschi S.W., Raney K.D., Stone M.P., and Harris T.M. Preparation of the 8,9-epoxide of the mycotoxin aflatoxin B1: the ultimate carcinogenic species. J Am Chem Soc 110 (1988) 7929-7931
43. El-Knobby T., Gala N., Fenwick A., Bearcat R., El-Hawley A., Noonan Z., et al. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg Suppl 2 (2000) 88-99
44. Nooman Z.M., Hasan A.H., Waheeb Y., Mishriky A.M., Ragheb M., Abu-Saif A.N., et al. The epidemiology of schistosomiasis in Egypt: Ismailia governorate. Am J Trop Med Hyg Suppl 2 (2000) 35-41
45. Michelson M.K., Azziz F.A., Gamil F.M., Wahid A.A., Richards F.O., Juranek D.D., et al. Recent trends in the prevalence and distribution of schistosomiasis in the Nile delta region. Am J Trop Med Hyg 1 (1993) 76-87
46. Pisani P., Parkin D.M., and Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 6 (1993) 891-903
47. Bedwani R., El-Khwsky F., El-Shazly M., Seif H.A., Zaki A., Renganathan E., et al. Hepatitis viruses, schistosomal infection and liver cancer in Egypt. Int J Cancer 5 (1996) 688-689
48. Mace K., Aguilar F., Wang J.S., Vautravers P., Gomez-Lechon M., Gonzalez F.J., et al. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 7 (1997) 1291-1297
49. Wang J.S., and Groopman J.D. DNA damage by mycotoxins. Mutat Res 1-2 (1999) 167-181
50. Yu M.W., Lien J.P., Chiu Y.H., Santella R.M., Liaw Y.F., and Chen C.J. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 2 (1997) 320-330
51. Yu M.W., Lien J.P., Liaw Y.F., and Chen C.J. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Cancer Epidemiol Biomarkers Prev 8 (1996) 613-619
52. Saeed H.M., Mostafa M.H., O'Connor P.J., Rafferty J.A., and Doenhoff M.J. Evidence for the presence of active cytochrome P450 systems in Schistosoma mansoni and Schistosoma haematobium adult worms. FEBS Lett 1-3 (2002) 205-209
53. Jackson P.E., Qian G.S., Friesen M.D., Zhu Y.R., Lu P., Wang J.B., et al. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res 1 (2001) 33-35
54. Denissenko M.F., Koudriakova T.B., Smith L., O'Connor T.R., Riggs A.D., and Pfeifer G.P. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene 23 (1998) 3007-3014
55. Coursaget P., Depril N., Chabaud M., Nandi R., Mayelo V., LeCann P., et al. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 6 (1993) 1395-1397
56. Bressac B., Kew M., Wands J., and Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 6317 (1991) 29-31
57. Hollstein M.C., Montesano R., Groopman J.D., Hainaut P., and Friesen M.D. Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry. Cancer Epidemiol Biomarkers Prev 12 (2005) 2956-2962
58. El-Kafrawy S.A., Abdel-Hamid M., El-Daly M., Nada O., Ismail A., Ezzat S., et al. P53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health 208 (2005) 263-270